Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.
Guide · Tirzepatide · United States
Compounded tirzepatide in the US: what it is, its legal status and who sells it
Compounded tirzepatide is tirzepatide prepared by a compounding pharmacy for an individual prescription, not the brand-name Zepbound and Mounjaro made by Eli Lilly. It is not FDA approved.[1] US online programs price it from $69 to $399 a month on a month to month plan (median $139 a month), in our read of November 19, 2026, usually for the lowest dose.
Since the tirzepatide shortage ended, pharmacies may no longer routinely compound copies of Zepbound; a prescriber can still order it for an individual patient with a documented clinical need, and the FDA has said it intends to restrict mass-marketed compounded GLP-1 products. This page sets out the legal position with dated sources, the FDA's safety concerns, who sells it online and how to check a seller. It is not legal or medical advice.
Is compounded tirzepatide legal in the US?
During a shortage, the FDA lets pharmacies compound copies of an approved drug. Once a shortage ends, that permission winds down. Key dates for tirzepatide:
- Oct 2, 2024: The FDA removed tirzepatide from its drug shortage list.[2]
- Dec 19, 2024: After re-evaluating the shortage, the FDA confirmed in a declaratory order that it was resolved.[2]
- Feb 18, 2025: The end of the period in which the FDA said it would not act against state-licensed 503A pharmacies compounding tirzepatide as they had during the shortage.[2],[3]
- Mar 19, 2025: The same date for 503B outsourcing facilities.[2],[3]
- Feb 6, 2026: The FDA said it intends to restrict the GLP-1 active ingredients used in mass-marketed compounded drugs that are not FDA approved, and that sellers may not claim such products are generic versions of, equivalent to or the same as FDA-approved drugs. It said it could seek seizures or injunctions.[6]
- March 2026: The FDA sent warning letters to 30 telehealth companies over misleading marketing of compounded GLP-1 products.[7]
- May 1, 2026: The FDA published a notice proposing not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, the list of substances outsourcing facilities may compound from bulk. A final determination is still pending.[8],[7]
What the rules allow now
- A 503A pharmacy (a state-licensed pharmacy compounding for an individual patient's prescription) may not regularly compound what the law calls "essentially a copy" of a commercially available drug: the same active ingredient, strength, dosage form and route as the approved product. That applies even when other ingredients are added.[4],[5]
- A prescriber can still order a compounded version for an individual patient when they document a clinically significant difference that the patient needs. Cost savings alone is not enough, and adding an ingredient such as vitamin B12 does not on its own make a product different.[4],[5]
- 503B outsourcing facilities generally may not lawfully compound these drugs, the Kentucky Board of Pharmacy told pharmacies in November 2025.[5]
- Sellers may not market a compounded product as a generic version of, equivalent to or the same as an FDA-approved drug.[6]
Is compounded tirzepatide safe? What the FDA says
- Compounded drugs are not FDA approved, and the FDA does not review them for safety, effectiveness or quality before they are marketed.[1]
- The FDA says compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.[1]
- As of May 31, 2026, the FDA had received more than 730 reports of adverse events associated with compounded tirzepatide, and it notes that adverse events are likely underreported.[1]
- The FDA has received reports of adverse events, some needing hospital care, that may be related to dosing errors, including patients measuring the wrong amount and professionals miscalculating doses.[1]
- The FDA warns of fraudulent compounded products whose labels carry false information, some listed under pharmacies that do not exist, and it has warned companies selling products falsely labeled "for research purposes" or "not for human consumption".[1]
- The FDA asks patients and clinicians to report side effects or quality problems through its MedWatch program.[1]
We give no dosing, storage or injection advice. Your prescriber and pharmacist should explain how to use any medicine they supply.
Who sells compounded tirzepatide online
24 US online programs print a compounded tirzepatide price on their own page. Each figure below is read daily from that page, with the day we read it; the latest read was November 19, 2026. A plan price is the per month figure of a prepaid plan, billed up front.
| # | Provider | Price | What the price is | Current offer | Checked | Link |
|---|---|---|---|---|---|---|
| 1 | Collectivetirzepatide | $69/mo | ongoing monthly price; plus a required $199 annual membershipPage wording: Compounded Tirzepatide $69/mo. Same price, any dose. | None recorded | See pricing | |
| 2 | welludrtirzepatide | $69/mo | Starting at, advertised sale price, per monthPage wording: BLACK FRIDAY SALE DISCOUNT APPLIED $39 /mo Semaglutide $69 /mo Tirzepatide | New Customer Offer: $150 off for LifeOffer end date not stated | See pricing | |
| 3 | Embodytirzepatide | $99/mo | advertised sale price, per monthPage wording: PRE-BLACK FRIDAY SALE DISCOUNT APPLIED! $49 Semaglutide / $99 Tirzepatide | PRE-BLACK FRIDAY SALE DISCOUNT APPLIED!Sale end recorded: Nov 24 | See pricing | |
| 4 | SnagRxtirzepatide | $109/mo | advertised sale price, per monthPage wording: PRE-BLACK FRIDAY SALE DISCOUNT APPLIED! Semaglutide for $59 / Tirzepatide for $109 | PRE-BLACK FRIDAY SALE DISCOUNT APPLIED!Standard price | See pricing | |
| 5 | Arbortirzepatide | $119/mo | From, ongoing monthly pricePage wording: Tirzepatide From $119/mo | None recorded | See pricing | |
| 6 | Trimitirzepatide | $125/mo | per month on a prepaid plan: 12-month plan, $1,500 billedPage wording: 12 months Lowest rate $125/mo $1,500 billed upfront | None recorded | Paused: not currently accepting new patients through our links. See alternatives | |
| 7 | Eden Healthtirzepatide | $129/mo | ongoing monthly pricePage wording: Tirzepatide $129 /mo | None recorded | See pricing | |
| 8 | GobyMedstirzepatide | $133/mo | Starting at, per month on a prepaid plan: 3-month starter bundle, $399 billedPage wording: Starting at $133/m Compounded Tirzepatide 3-Month Starter Bundle ... Total $399 | None recorded | See pricing | |
| 9 | bmiMDtirzepatide | $139/mo | Starting as low as, ongoing monthly pricePage wording: Compounded Tirzepatide Starting as low as $139/mo | None recorded | See pricing | |
| 10 | Yucca Healthtirzepatide | $139/mo | From, ongoing monthly pricePage wording: Monthly Plan Billed monthly · no commitment $139 /mo was $258/mo | None recorded | Paused: not currently accepting new patients through our links. See alternatives | |
| 11 | Healthy Living Clinictirzepatide | $149 | price per 4 weeks for 3 mg to 9 mg a week; ships as a 12-week box paid in 3 payments, one every 4 weeks, and all 3 are due once the box shipsPage wording: Tirzepatide - Intermediate Dose $149.00 /4weeks | None recorded | See pricing | |
| 12 | Strut Healthtirzepatide | $149 | From, price with no period statedPage wording: MONTHLY VIAL From $149 Monthly supply | None recorded | See pricing | |
| 13 | MEDVitirzepatide | $166/mo | advertised sale price, per monthPage wording: Friday Sale: Tirzepatide only $166/mo | Friday SaleOffer end date not stated | See pricing | |
| 14 | TMatestirzepatide | $167/mo | per month on a prepaid plan: 12 months, $1,999 billedPage wording: 12 Months$167/mo Save 44% $1999 | None recorded | Paused: not currently accepting new patients through our links. See alternatives | |
| 15 | Fridaystirzepatide | $198/mo | As low as, advertised sale price, per monthPage wording: Tirzepatide: As low as $198/mo | PRICE LOCKED IN FOREVEROffer end date not stated | See pricing | |
| 16 | REBLtirzepatide | $199/mo | From, ongoing monthly pricePage wording: Treatments from $199/mo | None recorded | ||
| 17 | Shedtirzepatide | $225/mo | Starting at, ongoing monthly pricePage wording: BLACK FRIDAY PRICE LOCKED FOREVER Compounded Tirzepatide $225 /mo was $299 Billed as $450 every 2 months | None recorded | See pricing | |
| 18 | Sprout Healthtirzepatide | $229/mo | Starting at, ongoing monthly pricePage wording: Compounded tirzepatide Starting at $229/mo | None recorded | See pricing | |
| 19 | Trimitirzepatide | $235/mo | ongoing monthly pricePage wording: Monthly $235/mo $235 billed every month | None recorded | Paused: not currently accepting new patients through our links. See alternatives | |
| 20 | Luvo Healthtirzepatide | $249 | price per 4 weeks, billed every 4 weeksPage wording: 4 weeks of injections, delivered every 4 weeks. $249 from your second delivery. | None recorded | See pricing | |
| 21 | PeterMDtirzepatide | $249/mo | ongoing monthly pricePage wording: Then $249 per month • billed quarterly • 60mg | None recorded | See pricing | |
| 22 | MEDGmtirzepatide | $269/mo | per month on a prepaid plan: 12-Month Supply, $3,228 billedPage wording: 12-Month Supply Billed every 12 months $3,228 $269/mo | None recorded | See pricing | |
| 23 | Bodybuilding.com GLP-1tirzepatide | $286/mo | per month on a prepaid plan: 3-month bundlePage wording: $286/mo on 3-month bundle | First month $209 (standard | See pricing | |
| 24 | TMatestirzepatide | $297/mo | ongoing monthly pricePage wording: Choose Your Plan 1 Month $297, $297 /month Includes medication and ongoing support | None recorded | Paused: not currently accepting new patients through our links. See alternatives | |
| 25 | GobyMedstirzepatide | $299/mo | ongoing monthly pricePage wording: Compounded Tirzepatide (GLP-1/GIP) Single Month $299+ One month at any dosage. | None recorded | See pricing | |
| 26 | Foundtirzepatide | $359/mo | ongoing monthly pricePage wording: Compounded tirzepatide 1 month $289/mo $359/mo | None recorded | See pricing | |
| 27 | MEDGmtirzepatide | $399/mo | ongoing monthly pricePage wording: Month to Month $279 for first month then $399/mo. | None recorded | See pricing | |
| 28 | Wellorithmtirzepatide | $399/mo | ongoing monthly pricePage wording: Compounded tirzepatide ongoing (every month) $399 | First month $279Offer end date not stated | See pricing |
Compounded medicines are not FDA-approved.
Source: FDA: Declaratory Order: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy) · United States · Decision February 21, 2025
Source: FDA: Federal Register notice — List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B · United States · Published May 1, 2026
Compounded tirzepatide vs Zepbound
The two are different products, so the price gap is not a discount on the same medicine. These are cash prices from our archive, each with the day we read it.
| Option | FDA approved | Lowest cash price we hold | Checked |
|---|---|---|---|
| Zepbound kwikpen (multi-dose pen) | Yes | $299 a month at Hims; membership $149/mo month to month, $39 the first month, billed separately | Nov 19, 2026 |
| Zepbound vial | Yes | $299 a month at Hims; membership $149/mo month to month, $39 the first month, billed separately | Nov 19, 2026 |
| Zepbound list price | Yes | $1,086.37, the published list price insurers are billed against | Nov 12, 2026 |
| Compounded tirzepatide, lowest | No | $69/mo month to month at Collective; usually the lowest dose | Nov 19, 2026 |
| Compounded tirzepatide, median | No | $139 a month, the median month to month price across 13 programs | Nov 19, 2026 |
Zepbound is reviewed by the FDA for safety, effectiveness and quality; compounded versions are not.[1]
How to check a compounded tirzepatide seller
- A named, state-licensed pharmacy fills the prescription, and the program tells you which one. The FDA's BeSafeRx campaign advises buying prescription medicines only from state-licensed online pharmacies; you can check a license with the state board of pharmacy.[9]
- The program or its pharmacy holds LegitScript certification, which you can look up by website address.[10]
- A licensed prescriber reviews your health history before anything is prescribed. Compounding by a 503A pharmacy rests on a prescription for an individual patient.[4],[5]
- The product is never sold "for research purposes" or "not for human consumption". The FDA has warned companies selling GLP-1 products under those labels.[1]
- The seller does not call its product a generic, an equivalent or the same as the brand-name medicine, which the FDA says it may not claim.[6]
Related guides
For what it costs month to month and on plans, with Zepbound beside it, see our guide to tirzepatide cost.
For every compounded tirzepatide price ranked lowest first, see cheapest tirzepatide online.
For brand-name cash prices by seller, see Zepbound cost without insurance.
The other compounded GLP-1 sold online has its own guide: compounded semaglutide, with its legal status, the FDA's concerns and who sells it.
For life on treatment, our GLP-1 diet plan covers what to eat, what to limit and how much protein, and our guide to GLP-1 microdosing lists which online programs offer it and what it costs.
Frequently asked questions
What is compounded tirzepatide?
Compounded tirzepatide is tirzepatide prepared by a compounding pharmacy for an individual prescription, rather than manufactured by Eli Lilly as Zepbound or Mounjaro. It is sold by US telehealth programs after an online review by a licensed prescriber. It is not FDA approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound and Mounjaro are FDA-approved medicines made by Eli Lilly. Compounded tirzepatide is made by a compounding pharmacy and is not FDA approved. In February 2026 the FDA said sellers may not claim a compounded product is a generic version of, equivalent to or the same as an FDA-approved drug.
Is compounded tirzepatide safe?
The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed, and says they should only be used when a patient's medical needs cannot be met by an approved drug. As of May 31, 2026 it had received more than 730 adverse event reports for compounded tirzepatide, some linked to dosing errors, and it warns about fraudulent products. Ask your prescriber about the risks for you.
Does compounded tirzepatide work?
The FDA has not reviewed compounded tirzepatide for effectiveness. The clinical trial results published for Zepbound apply to the FDA-approved product, and no FDA review shows that a compounded version performs the same way. A licensed prescriber can explain what is known for your situation.
Is compounded tirzepatide still available, or is it going away?
US online programs still list it: the table on this page shows 24 with a price we read on November 19, 2026. Since the shortage ended, a 503A pharmacy may no longer routinely compound copies of the approved drug, though a prescriber can still order it for an individual patient with a documented clinical need. In 2026 the FDA said it intends to restrict GLP-1 ingredients in mass-marketed compounded products and proposed keeping tirzepatide off the 503B bulks list; a final decision is still pending.
Is compounded tirzepatide FDA approved?
No. Compounded drugs are not FDA approved. The FDA-approved tirzepatide medicines are Zepbound and Mounjaro, made by Eli Lilly.
Where can I get compounded tirzepatide, and how much is it?
Through a licensed prescriber, usually at a US telehealth program, with a named, state-licensed pharmacy filling the prescription. In our latest read, month to month prices for compounded tirzepatide from US online programs run from $69 to $399 a month, with a median of $139 a month (checked November 19, 2026). Most are starting prices for the lowest dose, and some are sale prices. Our tirzepatide cost guide sets these beside Zepbound.
Sources
- FDA, "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss" (content current as of Oct 1, 2026). Read Nov 10, 2026.
- Foley & Lardner, "GLP-1 Drugs: FDA Removing Tirzepatide from Drug Shortage List", Dec 20, 2024. Read Nov 10, 2026.
- TechTarget, "FDA winds down GLP-1 compounding policies", Apr 1, 2025. Read Nov 10, 2026.
- Best Lawyers (Keith Lefkowitz), "The GLP-1 Shortage Has Ended. Can You Still Legally Compound?", Aug 21, 2025. Read Nov 10, 2026.
- Kentucky Board of Pharmacy, compounding compliance alert on GLP-1 and GIP/GLP-1 drugs, Nov 14, 2025. Read Nov 10, 2026.
- Pharmacy Times, "FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Products", Feb 12, 2026. Read Nov 10, 2026.
- Becker's Hospital Review, "FDA warns on compounded GLP-1s amid 1,700 safety reports", Sep 8, 2026. Read Nov 10, 2026.
- Federal Register, List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B (proposed), May 1, 2026. Read Nov 10, 2026.
- FDA, "About BeSafeRx" (content current as of Feb 18, 2025). Read Nov 10, 2026.
- LegitScript, Website Certification Status lookup. Read Nov 10, 2026.